MMN

Clinical trials for MMN explained in plain language.

Never miss a new study

Get alerted when new MMN trials appear

Sign up with your email to follow new studies for MMN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug challenges standard therapy for debilitating nerve disease

Disease control Recruiting now

This study is testing whether a new drug called empasiprubart works as well as or better than the current standard treatment (IVIg) for adults with multifocal motor neuropathy (MMN), a rare condition that causes muscle weakness. About 115 participants will be randomly assigned to…

Matched conditions: MMN

Phase: PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated Apr 02, 2026 05:41 UTC

MMN

Get alerted when new MMN trials appear

New drug challenges standard therapy for debilitating nerve disease